BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
+17.32%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.77B
AUM Growth
+$173M
(+11%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
80.46%
Holding
31
New
5
Increased
4
Reduced
1
Closed
–
Top Buys
| 1 |
Pharvaris
PHVS
|
+$89M |
| 2 |
BLUE
bluebird bio
BLUE
|
+$16.2M |
| 3 |
Savara
SVRA
|
+$13.5M |
| 4 |
RACB
Research Alliance Corp. II Class A Common Stock
RACB
|
+$10.3M |
| 5 |
ARYD
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
|
+$7.33M |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$107M |
Sector Composition
| 1 | Healthcare | 92.43% |
| 2 | Financials | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tango Therapeutics
TNGX
$727M
| $5.56M | 0.32% |
500,000
| – | – |
|
|
BLSA
27
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $5.15M | 0.29% |
487,500
| – | – |
|
|
OMEG
28
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| $3.96M | 0.22% |
+400,000
| New | +$3.96M |
|
|
FLACU
29
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
| $3.05M | 0.17% |
300,000
| – | – |
|
|
JYAC
30
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $2.95M | 0.17% |
300,000
| – | – |
|
31
MoonLake Immunotherapeutics
MLTX
$3.34B
| $2.55M | 0.14% |
250,000
| – | – |
|